The biomarkers worth tracking on a peptide cycle
A peptide cycle without labs is a vibes-based cycle. You can feel different, but you cannot tell whether what you feel is the peptide, the new sleep, the caffeine drop, or placebo. The right five or six biomarkers, pulled on a schedule, turn a protocol into something you can actually evaluate.
Why this is where most cycles fall short
Most users start a peptide cycle without a baseline. They feel subjectively better or worse a month in, call it a signal, and adjust. Without a pre-cycle lab panel, the post-cycle numbers have nothing to be compared against. The cycle produced real changes or it produced nothing, and you cannot tell the difference. Pulling labs is inconvenient, and the peptide community has a long history of either skipping them or treating them as optional. That is the gap this post addresses.
IGF-1
Insulin-like growth factor 1 is the downstream marker of growth-hormone-axis stimulation. If you are running CJC-1295, Ipamorelin, Sermorelin, Tesamorelin, or MK-677, IGF-1 is the single lab that tells you whether the cycle is doing what it is supposed to. A healthy young adult range is roughly 115 to 307 ng/mL according to Mayo Clinic reference ranges, with values shifting downward with age.
Baseline before starting, re-test at week four, and retest at the end of the on-window. A flat IGF-1 across a four-week cycle means either the dose is too low or the peptide is not reaching the tissue. A sharp IGF-1 rise above the top of the range on supraphysiologic doses is a conversation with your clinician, not a victory lap.
Fasting glucose and HbA1c
Any peptide that touches growth hormone signalling can affect insulin sensitivity. Fasting glucose is a point-in-time marker; HbA1c is a 90-day average. Together they catch glycemic drift before it becomes a clinical problem. The American Diabetes Association's 2024 standards of care list fasting glucose under 100 mg/dL and HbA1c under 5.7 percent as normal; 100 to 125 mg/dL and 5.7 to 6.4 percent are the prediabetic ranges.
If you are running a GLP-1 class peptide like Semaglutide or Tirzepatide, the trend goes the other direction: fasting glucose drops, HbA1c drops, and the question becomes whether you are titrating the peptide appropriately. Pull these before starting, at week eight, and at cycle end.
hs-CRP
High-sensitivity C-reactive protein is a marker of systemic inflammation. It matters for peptide cycles in two directions. For healing peptides like BPC-157 and TB-500, a high baseline hs-CRP should move down over a cycle if the peptide is addressing the underlying inflammation. For any cycle, a rising hs-CRP mid-protocol is a warning sign that something is not agreeing with you, whether that is the peptide itself or an unrelated process that the cycle is masking.
A hs-CRP under 1.0 mg/L is considered low cardiovascular risk by the American Heart Association. Baseline, mid-cycle, and end.
Lipid panel
Total cholesterol, LDL, HDL, triglycerides. Peptides that shift body composition, particularly GLP-1 and growth-axis classes, shift lipid numbers as a side effect of weight and muscle changes. Triglycerides drop first; LDL usually follows. If lipid numbers move the wrong way on a cycle, that is actionable information for your clinician and a reason to reconsider the protocol.
Testosterone (for anyone on HPTA-adjacent peptides)
Gonadorelin, Kisspeptin-10, hCG, and any other peptide touching the HPTA axis need testosterone tracked before, during, and after. Total and free testosterone together, with SHBG where the lab offers it. Ranges vary by age and by lab, so the trend within your own numbers matters more than the absolute value.
How often to pull labs
Baseline within two weeks of starting. First follow-up at week four for short-acting peptides, week six for longer cycles. End-of-cycle within a week of the last dose. Off-cycle follow-up at the four-week mark to see whether changes held or regressed. This pattern gives you five data points per cycle, which is enough to see a trend and not so many that lab costs pile up.
How Pepture helps
Pepture includes a biomarker log with schema for the labs above plus free fields for anything your clinician asks for. Values are time-aligned to your cycle day, so you can see the peptide dose alongside the lab draw on a single timeline rather than reconstructing the comparison from memory. The reconstitution calculator handles the dose side; the biomarker log handles the response side.